← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 7, 2016Last known activity
Apr 14, 2026
Acquired by Bristol-Myers Squibb on Dec 22, 2023
Timeline
2000s
- Jun 1, 2009
Karuna Pharmaceuticals— Founded
2020s
- Dec 22, 2023
Bristol-Myers Squibb— Acquired By
Drugs by trial phase (8 distinct, 20 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (28)
- NCT07257120Lead sponsorPhase 4Apr 14, 2026
- NCT07204418Lead sponsorPhase 1Oct 13, 2025
- NCT07118215Lead sponsorPhase 1Sep 29, 2025
- NCT06572449Lead sponsorPhase 3Dec 31, 2024
- NCT06729970Lead sponsorPhase 1Dec 23, 2024
- NCT06605950Lead sponsorPhase 1Oct 1, 2024
- NCT06585787Lead sponsorPhase 3Sep 26, 2024
- NCT06126224Lead sponsorPhase 3Dec 31, 2023
- NCT05980949Lead sponsorPhase 3Jul 11, 2023
- NCT05919823Lead sponsorPhase 3May 29, 2023
- NCT05643170Lead sponsorPhase 3Nov 8, 2022
- NCT05511363Study directorPhase 3Aug 23, 2022
- NCT05511363Lead sponsorPhase 3Aug 23, 2022
- NCT05304767Study directorPhase 3Mar 7, 2022
- NCT05304767Lead sponsorPhase 3Mar 7, 2022
Details
- Founded
- Boston, Massachusetts, US Jun 1, 2009
- Last known activity
- Apr 14, 2026